Delivery of an antisense oligonucleotide, ASO1, suppressed SNCA mRNA expression with a dose-responsive reduction in α-syn aggregates in a PFF model of PD and normalized striatal dopamine levels [50]. Here, SNCA is linked to Parkinson disease.